Modi Ventures
Venture capitalHouston · Seed–Series A · 22 people tracked
Investment thesis
Modi Ventures focuses on the convergence of technology and biology, investing early in platforms it calls the emerging 'bioeconomy.' The firm believes advances in genome sequencing and the combination of artificial intelligence with biology are transforming pharmaceuticals, therapeutics, diagnostics and prognostics, with broad implications for manufacturing, climate, agriculture, space and human health. It targets technology platforms that positively impact health, with particular emphasis on opportunities leveraging AI, microfluidics hardware, multiomics, precision medicine, synthetic biology, gene editing and living therapies. Modi invests in both funds and founders.
Source: firm website, verified Aug 3, 2026.
Team · 22 people
from the firm's website & curated & public directories
What they invest in
from 41 of 56 portfolio companiesBiotech ×26AI & Machine Learning ×21Deep Tech ×20Digital Health ×15Healthtech ×14Medical Devices ×12Longevity ×4Hardware ×3
HQs:United States×23United Kingdom×4Germany×1New Zealand×1
Who they back
founder profiles across 29 portfolio companiesFounding team size:solo founder×162 founders×53 founders×44+ founders×4
Where their founders studiedfrom 11 founders with education data
Scripps Research ×2University of California, Berkeley ×2
Investments · 56 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 22020 · 15 dated
Abingworth is a venture capital and private equity firm specializing in life sciences and healthcare investments across seed, development, and clinical co-development stages.
BiotechHealthtechLondon, GB
Co-investorsAbingworth
Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials
Pavle Jeremic(Founder & CEO)Jay Zaveri(Co-Founder & President)
Co-investors4DX VenturesAbstract VenturesArtis VenturesBlue Bear VenturesBoxGroupCalm Ventures+7 more
Antler is a global early-stage venture capital firm that invests in founders from first check through IPO, offering capital, network, and community.
Sector Agnostic
Magnus Grimeland(Founder)in
Co-investorsAC VenturesAgaeti VenturesAntler AustraliaElmehøj VenturesFarvatn VenturePeak+3 more
ARTIS Ventures is a venture capital firm investing in frontier technologies and breakthroughs primarily at the intersection of technology, biology, and healthcare.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Stuart Peterson(Founder and Managing Partner)
Atomic.ai combines machine learning and RNA biology to discover and develop RNA-based drugs.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Raphael Townshend(Founder & CEO)inManjunath Ramarao(Chief Scientific Officer)Stephan Eismann(Founding Scientist, Head of Machine Learning)inEsta Kor(Head of Business Operations)Brent Townshend(Head of ML Data Generation)
Co-investorsAIX VenturesAME Cloud VenturesGreylock PartnersNot Boring CapitalPlayground Global8VC
Brainomix, a spin-out from the University of Oxford, develops AI-powered imaging biomarkers and software that help physicians interpret medical images to support clinical decisions.
AI & Machine LearningDigital HealthMedical DevicesOxford, GB
Michalis Papadakis(CEO)Alastair Buchan(Co-founder; Oxford Professor of Stroke Medicine)
Cancer Focus Fund is a venture capital firm that invests in cancer-focused companies and life science ventures.
BiotechDigital HealthHealthtech
Ross P. Barrett(Managing General Partner)
Developing next-generation γδ T cell engagers as cancer therapies.
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Co-investorsCriteria Bio VenturesLifeArc VenturesMedical Incubator Japan K.K.Pathway BioventuresSound Bioventures
Draper Associates is a venture capital firm that invests across all sectors and geographies from pre-seed to Series A, with particular focus on frontier technologies including AI, robotics, crypto, blockchain, healthcare, and aerospace.
AI & Machine LearningCrypto & Web3Deep TechSector AgnosticSilicon Valley, US
Tim Draper(Founder)
Early develops a home urinalysis system that pairs a clinical-grade electrochemical reader with disposable urine tests to screen for markers of serious conditions such as urinary tract cancers, diabetes, kidney disease, and heart disease risk, plus wellness markers, delivering results to an app in under five minutes.
Digital HealthHealthtechMedical DevicesLondon, GB
D-J Collins(Founder)Mark Emberton(Chief Medical Officer)
Elemind makes a wearable neurotech sleep headband that measures EEG brain signals and delivers phase-locked acoustic stimulation to help users fall asleep faster and return to sleep after waking.
Deep TechDigital HealthHardwareHealthtechWellness & Fitness
David Wang(Co-Founder + CTO)inMeredith Perry(Co-Founder + CEO)inEd Boyden(Co-Founder)Nir Grossman(Co-Founder)Heather Read(Co-Founder + Science Advisor)Roshan Rajappa(COO)
Co-investorsEvolution VC PartnersGreen Meadow VenturesJoyance PartnersMetaplanetThe E14 FundThe Family Fund
Eridu develops networking infrastructure optimized for artificial intelligence workloads.
AI & Machine LearningCloud ComputingDeep TechHardwareSaratoga, US
Drew Perkins(CEO and founder)inBrian Kinard(Executive Officer)in
BoardJagdeep Singh(Director)Dipender Saluja(Director)Wen Hsieh(Director)Christian Gallagher(Director)
Co-investorsBosch VenturesCatapult VenturesMatter Venture PartnersSocratic PartnersZelda VenturesBlack Opal Ventures+12 more
Evidence-based longevity intelligence platform for healthcare systems.
Evity builds a platform that translates longevity and healthspan research into clinical tools and patient-accessible information.
AI & Machine LearningDigital HealthHealthtechLongevity
Larry Brilliantin
BoardDr. Larry Brilliant
Co-investorsMaC Venture Capital
Developing therapy for neuropsychiatric symptoms of dementia, including agitation/aggression in Alzheimer's.
Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.
BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE
Hans Moebius(Co-founder and CMO, Head of Clinical Operations)Anton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)
Co-investorsAndera PartnersFountain Healthcare PartnersLifeArc Ventures
First Spark Ventures is a venture capital firm that invests in deep tech startups focused on advanced compute, digital biology and biotech, and cyber-physical systems.
AI & Machine LearningBiotechDeep Tech
Co-investorsPerot JainLightspeed Venture Partners
Flagship Pioneering is a firm that builds and funds companies in life sciences and related fields, describing itself as focused on breakthroughs for people and the planet.
Co-investorsRenaissance Venture Capital
General Proximity develops proximity-based technologies for drug discovery and development.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Armand Cognetta(Founder)in
Co-investorsY Combinatorage1Felicis Ventures
Developing next-generation protein sequencing platform to redefine proteomics.
Co-investorsLexi Ventures
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Joshua Yang(Founder & CEO)Daniel Estandian(Founder)Ed Boyden(Founder)Josh Yang(Founder)in
BoardCraig Asher(Director)inJimmy Yun(Director)
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesLongeVCOMX Ventures+3 more
Groq designs and manufactures the LPU (Language Processing Unit), a chip purpose-built for AI inference, and operates GroqCloud, a platform for running inference workloads with low latency and cost efficiency across global data centers.
AI & Machine LearningCloud ComputingSemiconductorsPalo Alto, US
Jonathan Ross(Founder & CEO)inDouglas Wightman(Executive Officer, Director)
BoardChamath Palihapitiya(Director)
Co-investorsAcequia Capital (AceCap)Alumni VenturesB CapitalBasecamp FundBeyond CapitalBlueYard Capital+36 more
Healthier Capital is a venture capital firm that invests in technology-enabled healthcare companies seeking to reduce costs and improve care delivery.
Digital HealthFintechHealthtech
Amir Dan Rubin(CEO and Founding Managing Partner)
HealthTech Arkansas (HTA) helps medtech and healthtech companies from around the world enter the U.S. healthcare market by guiding U.S. strategy, arranging guaranteed hospital pilot projects and clinical trials through its coalition of clinical partners, and connecting them with U.S. investors.
Digital HealthHealthtechMedical Devices
Ignota Labs uses SAFEPATH, a proprietary AI platform combining machine learning with bioinformatics and cheminformatics data, to identify and resolve drug safety and toxicity problems.
AI & Machine LearningBiotechDeep Tech
Co-investorsAIX VenturesBlue Wire CapitalSustainable VenturesMontage Ventures
Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery.
AI & Machine LearningBiotechDigital HealthMedical DevicesNew York, US
Aris Tsirigos(Co-Founder)Matija Snuderl(Co-Founder)Daniel Orringer(Co-Founder)Travis Wold(Chief Executive Officer)Mikhail Teverovskiy(Chief Technology Officer)
Co-investorsVerge HealthTech Fund
Kamau Therapeutics develops targeted gene integration therapies to treat serious and life-threatening genetic diseases.
BiotechDeep TechHealthtechAustin, US
Matthew Porteus(Executive Officer, Director)Valentin Barsan(Executive Officer, Director)
BoardRaymond Kelleher(Director)Ness Bermingham(Director)
Co-investorsDraper AssociatesKhosla VenturesNeva Sgr.
Vinod Khosla(Co-founder)in
Co-investorsBeast VenturesCalm/Storm VCClean Energy VenturesPerot Jain
KOMO Biosciences develops genome engineering technology based on hyperactive large serine integrases to transform cell-based manufacturing of biologics and advanced therapies.
BiotechDeep Tech
Jennifer Manning(Founder & CEO)Thomas Page(Acting CTO)Matt Farabaugh(Acting CFO)Jesse B. Owens(Acting CSA)
BoardRay Tabibiazar(Chairman of the Board)
Co-investorsGenesis BioCapitalEshelman Ventures, LLC
Latus develops gene therapies based on novel AAV capsid variants matched to optimized routes of administration, aiming to target specific cell types and tissues to lower dose requirements, toxicity, and manufacturing costs.
AI & Machine LearningBiotechDeep Tech
Co-investors8VCDCVC (Data Collective)
LILA Sciences builds AI systems for autonomous scientific research and discovery across medicine, materials, energy, and defense sectors.
AI & Machine LearningBiotechDeep TechSaaS
Co-investorsCatalio Capital Management, LPDauntless VenturesFlagship PioneeringMarch Capital PartnersCollective GlobalIn-Q-Tel+1 more
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Co-investorsMission Biocapital4BIO CapitalCancer FundFitz Gate VenturesPortal InnovationsTMC Venture Fund+1 more
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
BiotechDeep TechMedical DevicesSeattle, US
Marc Lajoie(Co-founder & Chief Executive Officer)Scott Boyken(Co-founder & Chief Technology Officer)Stanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)inCharity Scripture(Executive Officer)Eric Soller(Executive Officer)
Co-investorsArtis VenturesRA CapitalAbstract VenturesAtinum Investment Co. Ltd.Civilization Ventures Management, LlcPlayground Global+1 more
PathPresenter is a digital pathology platform used for viewing, sharing, and managing pathology images in clinical, research, and educational settings.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Raj Singh(Founder)Rajendra Singh(Co-founder)inCory Batenchuk(Senior Vice President, Operations & Co-founder)inKV Acharya(System Architect & Co-founder)inPatrick Myles(Chief Executive Officer)in
Co-investorsAvant Bio
ProFound Therapeutics discovers and develops therapeutic candidates by analyzing the expanded human proteome, identifying novel proteins from previously uncharacterized genetic sequences that can serve as drug targets for cancer, immune disorders, and metabolic diseases.
AI & Machine LearningBiotechDeep Tech
Avak Kahvejian(Co-founder, Chairman)Yann Echelard(Co-founder)Vini Mani(Co-founder)Erica Weinstein(Co-founder)
BoardNoubar Afeyan
Co-investorsFlagship Pioneering
Prompt is an Ambient AI product and research company that develops human-centered AI products designed to sense the physical environment.
AI & Machine LearningConsumerDeep TechSan Francisco, US
Tete Xiao(Founder)in
Co-investorsAbstract VenturesAIX VenturesDCVC (Data Collective)Neotribe VenturesBraidwellCDP Venture Capital+3 more
Proxima is a biotech company developing proximity therapeutics through a drug discovery engine and a structural proteomics data platform.
AI & Machine LearningBiotechDeep Tech
Jonathan Bernardini(Founder)in
Co-investorsMagnetic VenturesDCVC (Data Collective)
Calabasas, US
Lord Barrington(Executive Officer)
Co-investorsInterplay Ventures Early Stage Management Llc
Discovers and develops medicines targeting pathologic cells that drive aging.
Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan.
AI & Machine LearningBiotechLongevityMedical Devices
Co-investorsBeiersdorf Innovation FundCDP Venture CapitalEvolution VenturesKhosla VenturesLongeVCMoonstone Venture Capital+1 more
Samsara BioCapital is a venture capital firm that invests in therapeutic and biotech companies, backing scientific teams developing new drugs and medical treatments.
BiotechDeep Tech
Dr. Srinivas Akkaraju(Founder and Managing General Partner)
Co-investorsBioBrit
Moxxie is a venture capital firm that invests at the pre-seed and seed stages in software and smart systems companies, requiring at least one technical founder and some evidence of product.
Sector Agnostic
Co-investorsFoundryNimble PartnersBloomberg BetaGoldman SachsSapphire Partners
S32 is a venture capital firm that invests in technology founders and companies, with particular focus on deep tech, AI, healthcare, and enterprise software.
AI & Machine LearningCybersecurityDeep TechEnterprise Software
Bill Maris(General Partner, Founder)Andy Harrison(General Partner, CEO)
Co-investorsSection 32Veronorte
Serif Biomedicines develops DNA-based therapies and nucleic acid delivery technologies for genetic medicine.
BiotechDeep TechDigital HealthMedical DevicesCambridge, US
Jacob Rubens(Chief Executive Officer)
Co-investorsFlagship Pioneering
Diagnostics, labs, and digital health platform for accessible detection and care at enterprise scale.
Dr. Sheena Menezes, PhD(Founder)in
Co-investorsKleiner PerkinsPortfoliaQuest Venture Partners
T.Rx Capital is a venture capital firm that invests in and helps build early-stage biotech, healthcare, and medical technology companies, focusing on drug discovery, advanced therapeutic modalities, medical devices, diagnostics, and healthcare software.
BiotechDigital HealthMedical Devices
Kwesi Frimpong-Boateng(Co-founder & Managing Partner)inMichael Langer(Co-founder & Managing Partner)inCorey M. McCann(Co-founder & Managing Partner)Robert Langer(Executive Chairman & Chair of Scientific Advisory Board)
Combines in-person clinic and online care for pet health.
Tandem Vet Care provides integrated in-person and online veterinary care for pet owners through a combination of physical clinics and digital health services.
ConsumerDigital HealthHealthtechSomerville, US
Techion develops FECPAK, a portable digital microscope and data platform that provides digital diagnosis and data management for animal, human, and environmental health, serving farmers and animal health specialists.
AgTechAI & Machine LearningData & InfrastructureDigital HealthMedical Devices
Greg Mirams(Founder and Managing Director)
Tiny Health offers at-home gut and vaginal microbiome test kits with age-specific, evidence-based reports that recommend diet, supplement, and lifestyle changes.
Digital HealthHealthtechWellness & Fitness
Cheryl Sew Hoy(Founder)in
Co-investorsB Capital GroupB4 CapitalCartan CapitalNext Coast VenturesNorth South VenturesOverwater Ventures Llc+6 more
Yosemite is working toward making cancer non-lethal, focusing on cancer research and treatment.
BiotechLongevitySan Francisco, US
Co-investors82VS
Zelda Ventures is an early-stage venture capital firm that provides first checks to startups led by serial entrepreneurs across a range of sectors.
Sector Agnostic
Suzanne Fletcher(Founder & Managing Partner)
Portfolio news
latest coverage across their companies
Early · techcrunch.com · Aug 20, 2026
San Francisco, CA · altss.com · Aug 11, 2026
Elemind · masslive.com · Aug 4, 2026
Atomic AI · eu-startups.com · Jul 31, 2026
Tiny Health · zeebiz.com · Jul 16, 2026
Proxima · finance.yahoo.com · Jul 7, 2026
Proxima · finance.yahoo.com · Jul 7, 2026
Frequently asked questions
- How many investments has Modi Ventures made?
- Modi Ventures has 55 tracked investments, including 1 dated in the last 24 months.
- What stage does Modi Ventures invest at?
- Modi Ventures invests at the Seed, Series A stages.
- What sectors does Modi Ventures focus on?
- Modi Ventures focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Healthtech, Longevity, Medical Devices, Space Tech.
- Where is Modi Ventures located?
- Modi Ventures is headquartered in Houston, US.
- Who does Modi Ventures co-invest with?
- Modi Ventures most often shares deals with Artis Ventures, Flagship Pioneering, Khosla Ventures, among 138 tracked co-investors.
Media · Podcasts & interviews
featuring the teamRaising a 32 million venture fund in 30 days - Sahir Ali (Modi Ventures)
Learning with Rishad · Sahir Ali
Images
Co-investors · 1
Parkwalk Advisors is a UK-based investment manager focused on backing deeptech companies spun out of UK universities, bridging the gap between academic research and commercial success. It operates as part of IP Group plc and is a leading EIS fund manager.
Firms observed investing alongside Modi Ventures, from public investor directories. Shared companies are the overlap with Modi Ventures's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Unruly Capital is a venture firm that backs founders working on ideas that seem too early or unconventional but are expected to become mainstream within a decade, focusing on frontier technology themes.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.